Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchronization: a multicentre study.
Lafitte S, Reant P, Zaroui A, Donal E, Mignot A, Bougted H, Belghiti H, Bordachar P, Deplagne A, Chabaneix J, Franceschi F, Deharo JC, Dos Santos P, Clementy J, Roudaut R, Leclercq C, Habib G. Lafitte S, et al. Among authors: zaroui a. Eur Heart J. 2009 Dec;30(23):2880-7. doi: 10.1093/eurheartj/ehn582. Epub 2009 Jan 9. Eur Heart J. 2009. PMID: 19136487
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.
Bézard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T. Bézard M, et al. Among authors: zaroui a. PLoS One. 2021 Sep 15;16(9):e0257189. doi: 10.1371/journal.pone.0257189. eCollection 2021. PLoS One. 2021. PMID: 34525116 Free PMC article.
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis.
Bézard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Gendre T, Audard V, El Karoui K, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T. Bézard M, et al. Among authors: zaroui a. Eur J Heart Fail. 2021 Feb;23(2):264-274. doi: 10.1002/ejhf.2028. Epub 2020 Nov 9. Eur J Heart Fail. 2021. PMID: 33094885 Free article.
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.
Kharoubi M, Roche F, Bézard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur JP, Damy T. Kharoubi M, et al. Among authors: zaroui a. ESC Heart Fail. 2021 Apr;8(2):1656-1665. doi: 10.1002/ehf2.13131. Epub 2020 Dec 22. ESC Heart Fail. 2021. PMID: 33354901 Free PMC article.
Prevalence and determinants of iron deficiency in cardiac amyloidosis.
Jobbé-Duval A, Bézard M, Moutereau S, Kharoubi M, Oghina S, Zaroui A, Galat A, Chalard C, Hugon-Vallet E, Lemonnier F, Eyharts D, Poulot E, Fanen P, Funalot B, Molinier-Frenkel V, Audard V, Hittinger L, Delbarre MA, Teiger E, Damy T. Jobbé-Duval A, et al. Among authors: zaroui a. ESC Heart Fail. 2022 Apr;9(2):1314-1327. doi: 10.1002/ehf2.13818. Epub 2022 Feb 6. ESC Heart Fail. 2022. PMID: 35128833 Free PMC article.
Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study.
Dang J, Segaux L, Moktefi A, Stehlé T, Kharoubi M, El Karoui K, Rémy P, Grimbert P, Plante-Bordeneuve V, Guendouz S, Galat A, Mallet S, Oghina S, Chadha GDS, Zaroui A, Fanen P, Canoui-Poitrine F, Damy T, Audard V. Dang J, et al. Among authors: zaroui a. Amyloid. 2023 Mar;30(1):38-48. doi: 10.1080/13506129.2022.2098011. Epub 2022 Jul 17. Amyloid. 2023. PMID: 35848215
34 results